Life Sciences / Biotech
The intellectual property lawyers and technical specialists of the Life Sciences/Biotech Practice Group use their legal, biotechnology and life sciences skills to evaluate current technologies and provide expert advice on intellectual property strategy and business development. They have years of experience in the pharmaceutical industry, technology transfer and licensing, life sciences patents and conducting intellectual property audits and due diligence studies. In addition to providing a full range of Life Sciences patent services, our clients look to us for licensing their technology or developing internal intellectual property policies and procedures.
The practice group includes patent attorneys and technical advisors who have years of experience and expertise in biotechnology, bioinformatics, immunology, agricultural biotechnology, gene therapy, genomics, medical devices, diagnostics, pharmaceuticals, proteomics, vaccines and drug delivery.
Many of our group members hold doctorate or advanced scientific degrees in immunology, biochemistry, botany, biotechnology and molecular biology. Many have worked as examiners at the United States Patent and Trademark Office (USPTO) or have held various positions in industry as researchers or in-house counsel.
We understand the complex USPTO procedures, as well as the scientific and business issues. This is what makes the difference for you. BSKB provides uniquely insightful technical advice and intellectual property legal counsel to a growing list of clients who enjoy the benefits of that added value.
Attorneys and Professionals
December 26, 2022
Key U.S. Supreme Court Developments in 2022 and Outlook for 2023
As the 2022 year comes to an end, Dr. Hailey Bureau reflects on the Intellectual Property industry and the key SCOTUS decisions of 2022 that impacted patent and trademark law.
October 11, 2022
"A new prescription for negative claim limitations"
World IP Review
Dr. Hailey Bureau was recently published in World IP Review’s latest digital edition of World IP Review.
March 8, 2023
Duty of Disclosure and Duty of Reasonable Inquiry
February 22, 2023
Pushing Back against Obviousness Rejections Unsupported by Evidence and Lacking Reasoned Explanations: A discussion of In re Google LLC.
February 8, 2023
LKQ CORP, KEYSTONE V. GM GLOBAL No. 2021-2348 (Fed. Cir. 2023)
November 16, 2022
Overview of AI Application and Related Issues
February 27, 2023
The electronic patent grant will be the official statutory patent grant effective April 18, 2023.
December 29, 2022
USPTO DOCX ANNOUNCEMENT
The U.S. Patent and Trademark Office (USPTO) has delayed the implementation of the non-DOCX filing surcharge until April 3, 2023.